Association of an Active Surveillance and Decolonization Program on Incidence of Clinical Cultures Growing Staphylococcus aureus in the Neonatal Intensive Care Unit
Staphylococcus aureus remains a leading cause of hospitalacquired infections (HAIs) in neonates. 1 Some neonatal intensive care units (NICUs) use active surveillance cultures (ASCs) and decolonization to prevent methicillin-resistant S. aureus (MRSA) transmission and infections. 2 However, methicillin-susceptible S. aureus (MSSA) infections occur more frequently and have similar mortality in neonates. 3 In The Johns Hopkins NICU, prior to April 2013, neonates were screened for MRSA colonization and carriers were decolonized. 4 In April 2013, the program expanded to include MSSA screening and decolonization. Previously, we showed that after implementation of MSSA ASCs and targeted decolonization, S. aureus clinical cultures and infections decreased. 4 Our objective was to assess whether the reduction was sustained over 3 years.
methods
Using The Johns Hopkins Pathology information system, we retrospectively identified neonates admitted to the NICU between April 1, 2011, and June 30, 2016 . Clinical cultures positive for Staphylococcus aureus were defined as nonsurveillance cultures growing S. aureus. Cultures from the same patient were considered unique events if they were collected from the same body site at least 30 days apart or from different body sites at least 14 days apart. NICU-attributable was defined as clinical cultures obtained >2 days after unit admission. A neonate was considered to have a bloodstream infection (BSI) if a blood culture grew S. aureus. Incidence rates for NICU-attributable S. aureus clinical cultures and BSIs and 95% confidence intervals (CI) were calculated for the pre-and post-intervention periods and were compared using 2-sample Poisson tests. Interrupted time series models were fit to the log-transformed quarterly incidence rates to quantify the immediate impact of the program, and the relative change in incidence rates per quarter during the pre-and postintervention period. 4 Our institutional review board approved this study. Overall, a 43% reduction in the incidence rate of S. aureus clinical isolates occurred when comparing the post-to the pre-intervention period (IRR, 0.57; 95% CI, 0.40-0.80) (Figure 1a) . Prior to the intervention, the incidence rate of S. aureus clinical cultures was estimated to increase at a nonsignificant rate of 14% per quarter (IRR, 1.14; 95% CI, 0.95-1.38). In the quarter following introduction of MSSA to the ASC program, we observed an immediate 65% decrease (IRR, 0.35; 95% CI, 0.15-0.82); thereafter, we observed an estimated 2.0% quarterly decrease in the incidence of NICUattributable S. aureus clinical cultures (IRR, 0.98; 95% CI, 0.92-1.05). The rate at which the incidence rates changed over time during the pre-and post-intervention periods did not differ statistically (estimated relative quarterly rate of change, 0.86; P = .12).
Prior to the intervention, there was no change in the incidence rate of BSIs (IRR, 1.00; 95% CI, 0.78-1.29). After implementation, there were statistically nonsignificant reductions (1) in the overall incidence rate of S. aureus BSIs (IRR, 0.50; 95% CI, 0.18-1.34) (Figure 1b) , (2) in the immediate change in rate of S. aureus BSIs (IRR, 0.73; 95% CI, 0.20-2.58), and (3) in the quarterly incidence rate of S. aureus BSIs (IRR, 0.97; 95% CI, 0.92-1.03).
With an average of 5.5 BSIs per year in the pre-intervention period, 18 BSIs were expected to occur in the post-intervention period, yet we observed 9. In the setting of ≥70% compliance with the decolonization protocol, 50% fewer infections occurred than expected, suggesting that 27 neonates were treated to prevent 1 BSI.
discussion
Our data suggest that an active MSSA screening and decolonization program in the NICU can lead to a sustained reduction (43% overall) in the incidence of clinical S. aureus isolates.
Prior studies have found that ASC and decolonization, in conjunction with other infection control measures, can reduce MRSA colonization and infection. 2, 5 The burden of MSSA infections exceeds that of MRSA infections in the NICU, 3 yet few studies have examined the impact of MSSA ASC and decolonization. Recently, Wisgrill et al 6 reported promising results of an MSSA surveillance and decolonization program that led to a 50% reduction of MSSA-attributable infections in very low-birthweight infants. Our study reports similar findings, and we included all neonates admitted to the NICU to reflect the impact on overall burden of S. aureus HAIs.
Efficacy, cost-effectiveness, and safety influence the decision to perform ASCs and decolonization. While neonatal data are limited, reports from adult populations suggest that active surveillance, targeted decolonization, and at times, universal decolonization are cost-effective compared to other prevention methods. 7 Possible unintended consequences of decolonization include replacing S. aureus with more virulent pathogens. However, in a multicenter NICU study examining MRSA decolonization, patients treated with mupirocin did not show increased risk of novel gram-negative and fungal infections. 8 Emerging resistance to mupirocin must also be considered with widespread use, but recent S. aureus ASC and decolonization programs have not found an increase in resistance to mupirocin. [4] [5] [6] 9 Incorporating MSSA screening into a NICU's infection control protocol may be an important step to reduce S. aureus infections in this vulnerable neonatal population.
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